Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]

13388 reported adverse events

Drugs of this class: ELOSULFASE ALFA GALSULFASE IDURSULFASE LARONIDASE TIVIDENOFUSP ALFA-EKNM

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] class:

# Side effect Count
0 PYREXIA 2297
1 COUGH 1082
2 PNEUMONIA 1024
3 DYSPNOEA 894
4 VOMITING 853
5 MALAISE 742
6 HEADACHE 599
7 PRODUCT DOSE OMISSION ISSUE 594
8 PAIN 590
9 FATIGUE 587
See all common reactions for Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CERVICAL CORD COMPRESSION 91 0.2507
1 EAR TUBE INSERTION 54 0.1824
2 SPINAL DECOMPRESSION 59 0.1398
3 KNEE DEFORMITY 128 0.0861
4 SPINAL CORD COMPRESSION 315 0.0808
5 CORNEAL OPACITY 102 0.0747
6 CORNEAL TRANSPLANT 54 0.0690
7 VASCULAR ACCESS COMPLICATION 55 0.0679
8 CATHETER SITE SWELLING 61 0.0652
9 CERVICAL SPINAL STENOSIS 108 0.0626
See all enriched reactions for Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]